Computed Tomography Market Size to Cross USD 10.92 Bn by 2032

Published Date : 14 May 2024

The global computed tomography market size surpassed USD 6.04 billion in 2023 and is estimated to cross around USD 10.92 billion by 2032, poised to grow at a CAGR of 6.80% from 2023 to 2032. The rising focus and awareness of preventive healthcare measures and growing technological advancements in computed tomography are anticipated to drive the growth of the computed tomography market.

Computed Tomography Market Size and Growth Rate From 2023 to 2032

Market Overview

The computed tomography market includes types of computed tomography, such as portable CT scanners and stationary CT scanners. Computed tomography refers to the procedure of computerized x-ray imaging in which a narrow beam of x-ray is aimed quickly rotated around the body and at a patient.

The increasing focus on mobile CT scanners, growing emphasis on early and effective disease diagnosis, rising demand for computed tomography scanners, and increasing number of CT scan procedures are expected to drive the growth of the market. In addition, the increasing prevalence of chronic diseases such as cardiovascular, orthopedics, and cancer diseases, increasing collaboration and partnerships between companies and hospitals, and rising product confirmation by regulatory authorities creating several new opportunities are anticipated to drive the growth of the computed tomography market during the forecast period.

The swift procedures, highly detailed images, and precise results fuel the market growth.

Computed tomography is a safe, fast, and pain-free procedure for patients. Patients who are referred to doctors and scanned efficiently can access results immediately. Computed tomography scans are produced to detect abnormalities, as well as highly detailed images and high-resolution images that do not appear in other scans. This is important when determining whether a patient reduces the need for exploratory surgery and requires surgery, not to mention that it plays a crucial role in the treatment and diagnosis of certain cancers.

In addition, the highly detailed images provide accurate and precise results, ensuring the best treatment plan for diagnosis, especially in the treatment of cancers and tumors. Computed tomography provides precise and clear diagnosis and accurately scans targeted parts of the patient’s body. This CT scan process is done by highly trained radiologists and radiographers and offers highly personalized patient care. These are the major driving factors anticipated to enhance the growth of the computed tomography market.

However, the restraint of computed tomography also causes toxic emission of radiation such as X-rays, which can have harmful effects on a patient’s health when the person is frequently exposed. During computed tomography scans, sometimes doctors may suggest the use of contrast, which may have some complications depending on the person's health, including toxic effects and allergic reactions on the body.

Some CT scans create some X-ray radiation and affect the patient’s body negatively, which may cause kidney problems. Some CT scans are time-consuming and expensive for routine healthcare checkups. Computed tomography may be affected by technical glitches. These are some challenging factors that may restrain the growth of the computed tomography market.

Computed Tomography Marke Report Scope

Report Coverage Details
Market Revenue in 2023 USD 6.04 Billion
Projected Forecast Revenue by 2032 USD 10.92 Billion
Growth Rate from 2023 to 2032 CAGR of 6.80%
Largest Market North America
Base Year 2022
Forecast Period 2023 to 2032
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa


Computed Tomography Market Top Companies

  • Fujifilm Corporation (Japan)
  • Philips Healthcare
  • Planmeca Oy (Finland)
  • Carestream Health (U.S)
  • Canon Medical Systems Corporation (Japan)
  • New Soft Medical Systems (China)
  • Koninklijke Philips N.V (Netherlands)
  • Siemens Healthineers AG (Germany)
  • Hitachi, Ltd. (Japan)
  • GE Healthcare (U.S.)

Recent Development by GE Healthcare

  • In May 2024, GE Healthcare launched Revolution RT, a computed tomography radiation therapy solution to simplify the pretend workflow to offer more seamless and personalized oncology care and to boost imaging accuracy for patients and clinicians.

Recent Development by Philips Healthcare

  • In March 2024, at the European Congress of Radiology, Philips Healthcare launched a new incorporation of artificial intelligence (AI) to enable CT scanners to improve image workflow and quality and features a new detector that was made to elevate the use of AI image reconstruction algorithms.

Regional Insights

Asia Pacific is expected to grow fastest during the forecast period. The increasing prevalence of chronic diseases among the population and increasing research and development with advanced technologies in computed tomography with increased performance and enhanced benefits are anticipated to drive the growth of the computed tomography market during the forecast period. India, China, Japan, and South Korea are the major emerging countries in the Asia Pacific region. China has the biggest market share and is the leading CT scan company.

In China, analytics provide comprehensive reports, and GlobalData uses proprietary data in the market. Due to a variety of reasons, such as geopolitical considerations, macroeconomic issues, prevalence and disease incidence, and population demographics, the Chinese market can contract and expand. In addition, the Chinese market also enhances as part of a process to generally improve medical practice, leading to a change in the treatment or diagnosis of patients and changes in clinical practice. Canon Medical Systems, Siemens Healthineers, and many more are major market players in the Chinese market. These are the major factors and major key players anticipated to drive the growth of the market.

North America dominated the computed tomography market in 2023. The rising introduction of technologically advanced systems in healthcare settings and the increasing number of patients undergoing diagnostic imaging procedures are anticipated to drive the growth of the market in North America. The U.S. and Canada are the major countries in North America.

The increasing prevalence of chronic diseases such as cancer, cardiovascular, and orthopedics diseases and the increasing aging population is expected to drive the growth of the market in the U.S. There are also top 10 companies of computed tomography in the U.S. such as GE Healthcare, Siemens Healthineers AG, Koninklijke Philips N.V., Neusoft Corporation, Carestream Health, Planmeca Oy, NeuroLogica Corp, and Hitachi Healthcare Americas. Computed tomography scanners are characterized by technological innovation and intense competition. These are the major factors, and leading companies are anticipated to drive the growth of the computed tomography market in North America.

Market Potential and Growth Opportunity

Artificial intelligence integration

Artificial intelligence will play an important role in the revolution of CT technology. AI technology can guide radiologists in automating routine tasks and image interpretation, which include anomaly identification, tumor detection, and organ segmentation. This advanced adoption of AI also assists in reducing healthcare costs, increasing efficiency, and improving diagnostic accuracy. Escalating patient demand, chronic staff shortages, and increasing financial pressures are enhancing the radiology departments, which helps avoid repeat scans and guarantee equipment uptime.

AI automates radiographers in time-consuming trends so that they can spend more time treating patients effectively. Major CT scan companies are using AI to enhance the seamless workflow features that help to deliver the speed and first-time-right image quality required for effective treatments by clinicians. These are the major opportunities anticipated to drive the growth of the computed tomography market in the coming future.

Computed Tomography Market News

  • In March 2024, the latest Echelon Synergy MRI Machine for its MRI and CT scans was launched by Fujifilm in India. The platform was a magnetic resonance imaging technology and explored the future of computed tomography. The company said that they deliver noise reduction, resulting in a 50% scan time reduction with the help of artificial intelligence (AI).
  • In April 2024, a pioneer in advanced diagnostic solutions, CDL Nuclear Technologies, launched the Mobile dedicated Cardiac CT/PET Trailer. This advanced and unique mobile solution is made to revolutionize cardiac care by offering CT/PET imaging services and state-of-the-art cardio to healthcare facilities on their schedule.

Segments Covered in the Report

By Technology

  • High slice
  • Mid slice
  • Low slice
  • Cone beam

By Application

  • Neurology
  • Orthopedics
  • Oncology
  • Cardiovascular
  • Respiratory
  • Gastrointestinal
  • Others

By Modality

  • O arm
  • C arm

By End-User 

  • Hospitals
  • Ambulatory surgery centers
  • Health clinics
  • Diagnostics imaging centers
  • Others

Buy this Research Report@ https://www.precedenceresearch.com/checkout/2221

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 650 460 3308